T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Okta
OKTA
$26B
| $7.85M | ﹤0.01% |
96,323
-11,288
| -10% | -$856K |
|
1102
DaVita
DVA
$11.6B
| $7.83M | ﹤0.01% |
82,849
-2,601
| -3% | -$265K |
|
1103
Alignment Healthcare
ALHC
$2.93B
| $7.81M | ﹤0.01% |
1,125,541
-181,746
| -14% | -$1.1M |
|
1104
Thryv Holdings
THRY
$95.5M
| $7.79M | ﹤0.01% |
414,807
+386
| +0.1% | +$8.56K |
|
1105
VF Corp
VFC
$5.78B
| $7.79M | ﹤0.01% |
440,504
+1,789
| +0.4% | +$34.1K |
|
1106
ING
ING
$102B
| $7.64M | ﹤0.01% |
579,626
+39,191
| +7% | +$552K |
|
1107
Allogene Therapeutics
ALLO
$697M
| $7.63M | ﹤0.01% |
2,407,347
-2,924,053
| -55% | -$12.8M |
|
1108
Affiliated Managers Group
AMG
$9.78B
| $7.58M | ﹤0.01% |
58,154
+24,551
| +73% | +$3.43M |
|
1109
Philips
PHG
$26.7B
| $7.51M | ﹤0.01% |
421,294
-63,546
| -13% | -$1.22M |
|
|
CMA
1110
DELISTED
Comerica
CMA
| $7.47M | ﹤0.01% |
179,768
+829
| +0.5% | +$39.3K |
|
1111
Brookfield
BN
$107B
| $7.45M | ﹤0.01% |
357,053
-1,533,787
| -81% | -$34.5M |
|
1112
Alector
ALEC
$230M
| $7.43M | ﹤0.01% |
1,146,967
+482,077
| +73% | +$3.12M |
|
1113
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $7.43M | ﹤0.01% |
195,687
+50,435
| +35% | +$2M |
|
1114
Ovintiv
OVV
$17.4B
| $7.4M | ﹤0.01% |
155,452
-23,886
| -13% | -$1.08M |
|
1115
Full Truck Alliance
YMM
$9.11B
| $7.37M | ﹤0.01% |
1,046,489
| – | – |
|
1116
NeoGenomics
NEO
$2.06B
| $7.31M | ﹤0.01% |
593,997
+11,309
| +2% | +$168K |
|
1117
Wave Life Sciences
WVE
$1.04B
| $7.3M | ﹤0.01% |
1,269,162
+1,213,995
| +2,201% | +$5.54M |
|
1118
W.P. Carey
WPC
$16.3B
| $7.29M | ﹤0.01% |
137,687
+3,679
| +3% | +$236K |
|
1119
Vesta Real Estate
VTMX
$3.15B
| $7.29M | ﹤0.01% |
221,740
-6,563
| -3% | -$233K |
|
1120
Fidelity National Financial
FNF
$13.3B
| $7.26M | ﹤0.01% |
175,672
+4,296
| +3% | +$172K |
|
1121
Dell
DELL
$318B
| $7.23M | ﹤0.01% |
104,932
+1,227
| +1% | +$73.1K |
|
1122
Genmab
GMAB
$19.5B
| $7.08M | ﹤0.01% |
200,718
-50,380
| -20% | -$1.92M |
|
1123
Ardelyx
ARDX
$1.05B
| $7.07M | ﹤0.01% |
1,732,167
-41,395
| -2% | -$161K |
|
1124
Twilio
TWLO
$36.8B
| $6.74M | ﹤0.01% |
115,065
+5,429
| +5% | +$338K |
|
1125
SAP
SAP
$241B
| $6.71M | ﹤0.01% |
51,885
+3,616
| +7% | +$492K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.